English court sides with Eli Lilly in Genentech jurisdictional clash
08-12-2017
RJohn97 / iStockphoto.com
Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Eli Lilly, Genentech, US District Court for the Southern District of California, psoriatic arthritis, plaque psoriasis, patent, patent infringement
